Proarrhythmic risk assessment using conventional and new in vitro assays. [electronic resource]
- Regulatory toxicology and pharmacology : RTP Aug 2017
- 1-11 p. digital
Publication Type: Journal Article
1096-0295
10.1016/j.yrtph.2017.05.012 doi
Action Potentials--drug effects Anti-Arrhythmia Agents--toxicity Arsenic--toxicity Dose-Response Relationship, Drug Drug Discovery Drug Evaluation, Preclinical--methods Fluoroquinolones--toxicity Humans In Vitro Techniques Induced Pluripotent Stem Cells--drug effects Long QT Syndrome--chemically induced Moxifloxacin Myocytes, Cardiac--drug effects Pentamidine--administration & dosage Phenethylamines--toxicity Risk Assessment Sulfonamides--toxicity